Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors
Lists
Only you see this
Abstract
A central challenge in cancer research is to identify the secreted factors that sustain tumor cell survival. This is best exemplified in Hodgkin lymphoma, where malignant cells constitute a minor fraction of the tumor and rely on signals from the microenvironment for survival. Using genome-wide transcriptional profiling with spatial and single-cell resolution, we show that the neighborhood around malignant cells forms a distinct niche of 31 non-malignant cell types, enriched in helper T cells and myeloid cells, but depleted of plasma cells. Moreover, our spatial analysis nominates IL13 as a candidate survival factor. Recombinant IL13 augments malignant cell growth in vitro, and genome-wide loss-of-function screens across >1000 human cancer cell lines identify IL4R and IL13RA1, heterodimeric components of the IL13 receptor, as uniquely essential in Hodgkin lymphoma. Importantly, blocking antibodies phenocopy genetic inactivation. Our findings provide a biological rationale for testing IL13-directed therapies, which are already FDA-approved, in Hodgkin lymphoma.
BibTeX
@inproceedings{shanmugam2025genome,
author = {Vignesh Shanmugam and Neriman Tokcan and Daniel Chafamo and Seán M. Sullivan and Mehdi Borji and Haley Martin and Gail Newton and Naeem Nadaf and Saoirse Hanbury and Irving A. Barrera and Dylan Cable and Jackson A. Weir and Orr Ashenberg and Geraldine Pinkus and Scott Rodig and Caroline Uhler and Evan Z. Macosko and Margaret A. Shipp and Abner Louissaint and Fei Chen and TR Golub},
title = {{Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors}},
booktitle = {Nature Communications},
year = {2025},
doi = {10.1038/s41467-025-67539-1},
}Loading related content...